21 C.F.R. Part 312
Investigational New Drug Application
AGeneral ProvisionsBInvestigational New Drug Application (IND)CAdministrative ActionsDResponsibilities of Sponsors and InvestigatorsEDrugs Intended to Treat Life-threatening and Severely-debilitating IllnessesFMiscellaneousGDrugs for Investigational Use in Laboratory Research Animals or In Vitro TestsH[Reserved]IExpanded Access to Investigational Drugs for Treatment Use